These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3874600)

  • 1. [Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes].
    Suzuki F
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1445-52. PubMed ID: 3874600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
    Suzuki F; Brutkiewicz RR; Pollard RB
    Anticancer Res; 1985; 5(5):479-83. PubMed ID: 3877491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ability of sera from mice treated with Ge-132, an organo-germanium compound, to inhibit experimental murine ascites tumors].
    Suzuki F
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2314-21. PubMed ID: 3935051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor mechanisms of carboxyethyl-germanium sesquioxide (Ge-132) in mice bearing Ehrlich ascites tumors].
    Suzuki F
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):127-34. PubMed ID: 3800401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activities and antitumor mechanism of an immunopotentiating organogermanium compound, Ge-132 (review).
    Brutkiewicz RR; Suzuki F
    In Vivo; 1987; 1(4):189-203. PubMed ID: 2979786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor effect in mice of an organic germanium compound (Ge-132) when different administration methods are used].
    Aso H; Shibuya E; Suzuki F; Nakamura T; Inoue H; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2345-51. PubMed ID: 4073929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Suppression of tumor growth by peritoneal macrophages isolated from mice treated with carboxyethylgermanium sesquioxide (Ge-132)].
    Suzuki F
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2122-8. PubMed ID: 4062310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours.
    Suzuki F; Brutkiewicz RR; Pollard RB
    Br J Cancer; 1985 Nov; 52(5):757-63. PubMed ID: 3933536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Lyt 1+ T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli.
    Suzuki F; Brutkiewicz RR; Pollard RB
    J Natl Cancer Inst; 1986 Aug; 77(2):441-7. PubMed ID: 3090339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
    Suzuki F; Brutkiewicz RR; Pollard RB
    Anticancer Res; 1986; 6(2):177-82. PubMed ID: 3085573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma (3LL) in C57BL/6 (B6) mice.
    Kumano N; Ishikawa T; Koinumaru S; Kikumoto T; Suzuki S; Nakai Y; Konno K
    Tohoku J Exp Med; 1985 May; 146(1):97-104. PubMed ID: 4024087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of combination immunochemotherapy with an organogermanium compound, Ge-132, and antitumor agents on C57BL/6 mice bearing Lewis lung carcinoma (3LL)].
    Kobayashi H; Komuro T; Furue H
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2588-93. PubMed ID: 2427032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor growth and metastasis in association with modification of immune response by novel organic germanium compounds.
    Sato I; Yuan BD; Nishimura T; Tanaka N
    J Biol Response Mod; 1985 Apr; 4(2):159-68. PubMed ID: 3998767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor properties of organometallic metallocene complexes of tin and germanium.
    Köpf-Maier P; Janiak C; Schumann H
    J Cancer Res Clin Oncol; 1988; 114(5):502-6. PubMed ID: 3182909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of polysaccharide TC-13 on allogeneic and syngeneic tumors in mice.
    Kohno M; Abe S; Yamazaki M; Mizuno D
    Gan; 1982 Jun; 73(3):488-94. PubMed ID: 7129013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of transplantable tumors in mice by monomethylformamide].
    Smoryzanova OA; Proskuriakov SIa; Dedenkov AN; Riabchenko NI
    Vopr Onkol; 1989; 35(8):967-70. PubMed ID: 2800445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
    Fuyama S; Komatsu H; Arai S
    Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of NK-421 (Bestatin) and Ge-132 on the cytotoxicity of spleen cells obtained from the tumor-bearing mice].
    Ono M; Oka T; Yoshihara H; Tanaka N; Miwa H; Mannami T; Konaga E; Orita K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1771-7. PubMed ID: 7184374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.